Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
This will be a randomized, open-label, active-controlled, 6-period crossover study. Target
population will be subjects with Type 2 Diabetes Mellitus (T2DM)